Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.

MLA

Ding, Dafa, et al. “Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.” Frontiers in Cellular and Infection Microbiology, vol. 12, Mar. 2022, p. 820367. EBSCOhost, https://doi.org/10.3389/fcimb.2022.820367.

APA

Ding, D., Yong, H., You, N., Lu, W., Yang, X., Ye, X., Wang, Y., Cai, T., Zheng, X., Chen, H., Cui, B., Zhang, F., Liu, X., Mao, J.-H., Lu, Y., & Chang, H. (2022). Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients. Frontiers in Cellular and Infection Microbiology, 12, 820367. https://doi.org/10.3389/fcimb.2022.820367

Chicago

Ding, Dafa, Huijuan Yong, Na You, Wei Lu, Xu Yang, Xiaolong Ye, Yayun Wang, et al. 2022. “Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients.” Frontiers in Cellular and Infection Microbiology 12 (March): 820367. doi:10.3389/fcimb.2022.820367.